MCAM and type 2 diabetes mellitus: Besides, ECFCs from T2DM patients have been found to exhibit reduced proliferative and migratory abilities [112], and EPCs (Dil-acLDL+ FITC‐UEA‐I+ CD34+ CD31+CD146+KDR+) isolated from T2DM patients showed reduced proliferation, adhesion and tube forming ability [113].